Pharma News India
Cipla has launched the generic version of Advair in Germany and Sweden.
Mumbai, September 3, 2014: Cipla has launched an anti-asthma inhaler in Germany and Sweden, which is a generic version of GlaxoSmithKline Plc's Advair. The company said in a statement that it will be marketing the new drug under the name Serrofloin in Germany and Salmeterol/Fluticasone Cipla in Sweden.
The Status has been granted to WCK 771 and WCK 2349.
New Delhi, August 31, 2014: The Indian drug maker Wockhardt has received Qualified Infectious Disease Product (QIPD) status on two of its drugs from the US health regulator.
The company has entered the oncology segment with the discovery of a new molecule.
New Delhi, August 25, 2014: Glenmark Pharmaceuticals has entered the oncology segment with the discovery of a new molecule. The company plans to develop and treat various types of cancers with the recent discovery.
The deadline to affix barcodes on mono-carton has been extended to April 2015.
New Delhi, August 18, 2014: The Government of India has extended the deadline to affix the barcodes on mono-cartons (ointment, eye/ear drops) by the pharma companies to April 2015. It may be noted that barcodes are expected to help in tracking and tracing the origin of drugs, which minimises the chance ...
The credit rating firm expects an increase of 40% in the Capex of India's top 20 pharma companies.
Mumbai, August 13, 2014: The top 20 pharmaceutical companies are expected to increase the capital expenditure (Capex) by 40 per cent to over Rs 50,000 crore by FY18, according to the credit rating firm Crisil. The increase in the capex is because of a higher attention towards the US ...